Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742579015 | Product containing only rotigotine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3742580017 | Rotigotine only product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rotigotine only product in transdermal dose form | Is a | Rotigotine only product | true | Inferred relationship | Some | ||
| Rotigotine only product in transdermal dose form | Is a | Rotigotine-containing product in transdermal dose form | true | Inferred relationship | Some | ||
| Rotigotine only product in transdermal dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Rotigotine only product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some | ||
| Rotigotine only product in transdermal dose form | Has active ingredient | Rotigotine | true | Inferred relationship | Some | 1 | |
| Rotigotine only product in transdermal dose form | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rotigotine 83.333 microgram/hour prolonged-release transdermal patch | Is a | True | Rotigotine only product in transdermal dose form | Inferred relationship | Some | |
| Rotigotine 166.667 microgram/hour prolonged-release transdermal patch | Is a | True | Rotigotine only product in transdermal dose form | Inferred relationship | Some | |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Is a | True | Rotigotine only product in transdermal dose form | Inferred relationship | Some | |
| Rotigotine 125 microgram/hour prolonged-release transdermal patch | Is a | True | Rotigotine only product in transdermal dose form | Inferred relationship | Some | |
| Rotigotine 41.667 microgram/hour prolonged-release transdermal patch | Is a | True | Rotigotine only product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR